Screening of H-ras gene point mutations in 50 cases of bladder carcinoma

International Journal of Urology

Volumn 4, Issue 2, 1997, Pages 178-185

  Saito, Shiro ^a   Hata, Makoto ^a   Fukuyama, Ryuichi ^a   Sakai, Kosuke ^a   Kudoh, Jun ^a   Tazaki, Hiroshi ^a   Shimizu, Nobuyoshi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Bladder neoplasms; Diagnosis; H ras oncogene; Point mutation

Indexed keywords

RESTRICTION ENDONUCLEASE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; BLADDER MUCOSA; CANCER DIAGNOSIS; CLINICAL ARTICLE; CODON; DOT HYBRIDIZATION; EARLY DIAGNOSIS; FEMALE; GENETIC SCREENING; HUMAN; HUMAN TISSUE; MALE; ONCOGENE H RAS; POINT MUTATION; PRIORITY JOURNAL;

EID: 0030937967     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1997.tb00167.x     Document Type: Article

References (27)

1. Cooper GM. Cellular transforming genes. Science 1982;218:801-806.
2. Land H, Parada LF, Weinberg RA. Cellular oncogenes and multi-step carcinogenesis. Science 1983;222:771-778.
3. Shih TY, Weeks MO, Young HA, Scolnick EM. Identification of a sarcoma virus-coded phosphoprotein in nonproducer cell transformed by Kirsten or Harvey murine sarcoma virus. Virology 1979;95:64-79.
4. Barbacid M. ras genes. Ann Rev Biochem 1987; 56:779-827.
5. Bos JL. The ras gene family and human carcinogenesis. Mutat Res 1988;195:255-271.
6. Almoguera C, Shibata D, Forrest K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras gene. Cell 1988; 53:549-554.
7. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ, Vogelstein B. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987;327:293-297.
8. Nagata Y, Abe M, Kobayashi K, Saiki S, Kotake T, Yoshikawa K, Ueda R, Nakayama E, Shiku H. Point mutations of c-ras genes in human bladder cancer and kidney cancer. Jpn J Cancer Res 1990;81:22-27.
9. Fujita J, Yoshida O, Yuasa Y, Rhim JS, Hatanaka M, Aaronson SA. Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumors. Nature 1984;309:464-466.
10. Fujita J, Srivastava SK, Kraus MH, Rhim JS, Tronick SR, Aaronson SA. Frequency of molecular alterations affecting ras proto-oncogenes in human urinary tract tumors. Proc Natl Acad Sci USA 1985;82:3879-3853.
11. Visvanathan KU, Pocock RD, Summerhayes IC. Preferential and novel activation of H-ras in human bladder carcinomas. Oncol Res 1988;3:77-86.
12. Knowles MA, Williamson M. Mutation of H-ras is infrequent in bladder cancer: confirmation by single-strand conformation polymorphism analysis, designed restriction fragment length polymorphisms, and direct sequencing. Cancer Res 1993;53:133-139.
13. Harmer MH. TNM classification of malignant tumors. 3rd ed. Geneva: International Union Against Cancer 1978.
14. Koss LG. Tumors of the urinary bladder. In: Atlas of tumor pathology. Vol. 11. Washington DC: Armed Forces Institute of Pathology, Fasc, 1975;16.
15. Janssen JWG, Steenvoorden ACM, Collard JG, Nusse R. Oncogene activation in human myeloid leukemia. Cancer Res 1985;45:3262-3267.
16. Shibata DK, Arnheim N, Martin WJ. Detection of human papilloma virus in paraffin-embedded tissue using polymerase chain reaction. J Exp Med 1988;167:225-230.
17. Reddy EP. Nucleotide sequence analysis of the T24 human bladder carcinoma oncogene. Science 1983; 220:1061-1063.
18. Kraus MH, Yuasa Y, Aaronson SA. A position 12-activated h-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. Proc Natl Acad Sci USA 1984; 81:5384-5388.
19. Sekiya T, Fushimi M, Hori H, Hirohashi S, Nishimura S, Sugimura T. Molecular cloning and the total nucleotide sequence of the human c-Ha-ras-1 gene activated in a melanoma from a Japanese patient. Proc Natl Acad Sci USA 1984;81:4771-4775.
20. Heim S, Mitelman F. Nineteen of 26 cellular oncogenes precisely localized in the human genome map to one of the 83 bands involved in primary cancer-specific rearrangements. Hum Genet 1987;75:70-72.
21. Reddy EP, Reynolds RK, Santos E, Barbacid M. A point mutation is responsible for the acquisition of transforming properties of the T24 human bladder carcinoma oncogene. Nature 1982;300:149-152.
22. Taparowsky E, Suard Y, Fasano O, Shimizu K, Goldfarb M, Weigler M. Activation of T24 bladder carcinoma transforming gene linked to a single amino acid change. Nature 1982;300:762-765.
23. Gilman AG. G proteins: transducers of receptor-generated signals. Ann Rev Biochem 1987;56:615-649.
24. Gibbs JB, Sigal IS, Poe M, Scolnick EM. Intrinsic GTPase activity distinguishes normal and oncogenic ras p21 molecules. Proc Natl Acad Sci USA 1984; 81:5704-5708.
25. Hayashi K, Kakizoe T, Sugimura T. In vivo amplification and rearrangement of the c-Ha-ras-1 sequence in a human bladder carcinoma. Jpn J Cancer Res 1983; 74:798-801.
26. Barbacid M. Oncogenes and human cancer: cause or consequence? Carcinogenesis 1986;7:1037-1942.
27. McMahon G, Davis E, Wogan GN. Characterization of enzymatically amplified DNA from carcinogen-induced tumors. Proc Natl Acad Sci USA 1987;84:4974-4978.